Literature DB >> 2964845

Water-soluble contrast media in radiography of small bowel obstruction. Comparison of ionic and non-ionic contrast media.

A Stordahl1, F Laerum, T Gjølberg, I Enge.   

Abstract

Fifty patients with possible gastrointestinal obstruction, referred for enteric follow-through examination, were randomized for a double-blind, parallel comparison of the hyperosmolar contrast medium Gastrografin and the low-osmolar Omnipaque. The result was that Omnipaque retained its radiographic density in the small bowel better than Gastrografin. Omnipaque was thus a better alternative than Gastrografin in follow-through examinations of intestinal obstruction. Also, 23 patients out of 28 with small bowel obstruction due to peritoneal adhesions, had spontaneous relief of symptoms during the observation period following contrast medium ingestion with no significant difference between the two media. This indicated that enteric follow-through procedures may have a therapeutic efficacy similar to the treatment of small bowel obstruction using nasogastric suction and gastrointestinal rest. Possible mechanisms for this action of the contrast media are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2964845

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  14 in total

Review 1.  Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Water soluble, small bowel follow through for adhesive small bowel obstruction.

Authors:  Usman Jaffer; Abdel Rahman Omer
Journal:  Emerg Med J       Date:  2006-09       Impact factor: 2.740

2.  Diagnostic Value of Plain and Contrast Radiography, and Multi-slice Computed Tomography in Diagnosing Intestinal Obstruction in Different Locations.

Authors:  Liu Jun; Sun ChangYi
Journal:  Indian J Surg       Date:  2015-04-14       Impact factor: 0.656

Review 3.  [Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review].

Authors:  S Bader; M Weber; G Becker
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

4.  The value of water-soluble contrast radiology in the management of acute small bowel obstruction.

Authors:  A W Mitchell; J M Gibson
Journal:  Ann R Coll Surg Engl       Date:  1993-03       Impact factor: 1.891

5.  Effect of water-soluble contrast in colorectal surgery: a prospective randomized trial.

Authors:  Jia-Hui Chen; Chung-Bao Hsieh; Pei-Chieh Chao; Hsiao-Dung Liu; Chung-Jueng Chen; Yao-Chi Liu; Jyh-Cherng Yu
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

6.  Oral gastrografin radiography for the evaluation of the functional impact of peritoneal carcinomatosis: Correlation with clinicopathological findings.

Authors:  Lie-Jun Mei; Lin-Wei Wang; Chao-Qun Huang; Xiao-Jun Yang; Yan Li
Journal:  Mol Clin Oncol       Date:  2015-06-09

7.  Impact of gastrografin in clinical practice in the management of adhesive small bowel obstruction.

Authors:  Sanket Srinivasa; Nainoor Thakore; Saleh Abbas; Maryam Mahmood; Arman Adam Kahokehr; Andrew G Hill
Journal:  Can J Surg       Date:  2011-04       Impact factor: 2.089

8.  Therapeutic value of gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective randomized trial.

Authors:  Hok-Kwok Choi; Kin-Wah Chu; Wai-Lun Law
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

9.  Prospective evaluation of oral gastrografin(®) in the management of postoperative adhesive small bowel obstruction.

Authors:  Nasrin Rahmani; Reza Ali Mohammadpour; Peyman Khoshnood; Amirhossein Ahmadi; Sara Assadpour
Journal:  Indian J Surg       Date:  2012-04-13       Impact factor: 0.656

Review 10.  Water-soluble contrast medium (gastrografin) value in adhesive small intestine obstruction (ASIO): a prospective, randomized, controlled, clinical trial.

Authors:  Salomone Di Saverio; Fausto Catena; Luca Ansaloni; Margherita Gavioli; Massimo Valentino; Antonio Daniele Pinna
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.